HEIDELBERG PHARMA Trademark

Trademark Overview


On Friday, August 3, 2018, a trademark application was filed for HEIDELBERG PHARMA with the United States Patent and Trademark Office. The USPTO has given the HEIDELBERG PHARMA trademark a serial number of 88064933. The federal status of this trademark filing is REGISTERED as of Tuesday, March 31, 2020. This trademark is owned by Heidelberg Pharma AG. The HEIDELBERG PHARMA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use

Pharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparat...

Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies

Pharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
heidelberg pharma

General Information


Serial Number88064933
Word MarkHEIDELBERG PHARMA
Filing DateFriday, August 3, 2018
Status700 - REGISTERED
Status DateTuesday, March 31, 2020
Registration Number6021542
Registration DateTuesday, March 31, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 14, 2020

Trademark Statements


Indication of Colors claimedThe color(s) blue and light blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMA"
Description of MarkThe mark consists of a blue circle within another light blue partial circular design, to the right of which appears the stylized word "Heidelberg" in blue letters. Appearing within the partial circular design, and under the word "Heidelberg" is the stylized word "PHARMA" in blue upper-case letters.
Goods and ServicesBiochemicals, namely, monoclonal antibodies for in vitro scientific or research use
Goods and ServicesPharmaceutical preparations for the treatment of immuno oncological disorders, namely, cancer; pharmaceuticals for cancer therapy; chemico-pharmaceutical preparations for cancer therapies; pharmaceutical preparations and substances for use in the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; pharmaceutical preparations for human use, namely, for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; clinical diagnostic reagents; diagnostic chemical reagents for medical use; anti-cancer drugs; compounds for treating cancer; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing
Goods and ServicesPharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; laboratory services relating to the production of monoclonal antibodies
Goods and ServicesPharmaceutical advice; pharmaceutical services, namely, providing pharmaceutical advice and consultation and dispensing drugs to patients with cancer; consultancy and medical information services relating to pharmaceutical products
Section 2(f) Limitation StatementAs to "HEIDELBERG PHARMA"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, April 26, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 9, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 9, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeidelberg Pharma AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLadenburg 68526
DE

Party NameHeidelberg Pharma AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLadenburg D-68526
DE

Party NameHeidelberg Pharma AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLadenburg D-68526
DE

Trademark Events


Event DateEvent Description
Tuesday, January 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 5, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 5, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 5, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 5, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 31, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, January 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 12, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, December 12, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, November 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 16, 2019ASSIGNED TO LIE
Monday, November 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 9, 2019NON-FINAL ACTION E-MAILED
Thursday, May 9, 2019NON-FINAL ACTION WRITTEN
Friday, April 26, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 26, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 26, 2018NON-FINAL ACTION E-MAILED
Monday, November 26, 2018NON-FINAL ACTION WRITTEN
Wednesday, November 21, 2018ASSIGNED TO EXAMINER
Friday, August 10, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, August 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 7, 2018NEW APPLICATION ENTERED IN TRAM